Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Allostim |
Trade Name | |
Synonyms | |
Drug Descriptions |
Allostim is a preparation of allogeneic CD4-positive Th1-like T-cells bound to microparticles coated with anti-CD3 and anti-CD28 antibodies, which potentially induces antitumor immune response (NCI Thesaurus, J Clin Oncol 2025 43:4_suppl, TPS318). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C71540 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Allostim | Allostim | 0 | 1 |
Allostim + Avelumab | Allostim Avelumab | 0 | 1 |